S Choi1, B G Jeon2, G Chae1, S-J Lee3. 1. Department of Surgery, Kangwon National University School of Medicine, Kangwon National University Hospital, Chuncheon, South Korea. 2. Department of Surgery, Daejin Medical Center, Bundang Jesaeng General Hospital, Sungnam-Si, South Korea. 3. Department of Surgery, Chungbuk National University College of Medicine, Chungbuk National University Hospital, 1 Chungdae-ro, Seowon-gu, Cheongju, 28644, South Korea. colon@chungbuk.ac.kr.
Abstract
BACKGROUND: Treatment of complex anal fistulas remains difficult. However, treatment with stem cells has had an encouraging success rate when applied to complex perianal fistulas. We systematically reviewed the current evidence through meta-analysis. METHODS: We performed an electronic literature search on PubMed, Embase, and the Cochrane Library and identified studies (published between January 1946 and August 2017) that used stem cells to treat patients with complex perianal fistula. Each paper was evaluated for treatment success rate, target patients, types of stem cells used, number of cells used, and criteria for complete healing. Potential publication bias was assessed via visual inspection of a funnel plot and Orwin's fail-safe N. Out of 171 papers, 16 were included in the meta-analysis. RESULTS: The overall healing rate of stem cell injection therapy for patients with complex perianal fistulas was 62.8% (95% CI 53.5-71.2, I2 = 54.05%), whereas those for patients with Crohn's perianal fistulas alone and complex anal fistulas not associated with Crohn's disease were 64.1% and 61.5% (p = 0.840), respectively. Healing rates for autologous and allogenic stem cell treatment were 69.4% and 50.7% (p = 0.020), respectively. Four comparative studies out of 16 studies were analyzed separately. Stem cell therapy increased the healing rate compared to the control groups (OR 0.379, 95% CI 0.152-0.947). CONCLUSIONS: Stem cell therapy is a good treatment option for complex perianal fistulas, which cannot be healed by conventional operative procedures. However, further research for additional supportive evidence, such as a large-scale randomized controlled trial, is required.
BACKGROUND: Treatment of complex anal fistulas remains difficult. However, treatment with stem cells has had an encouraging success rate when applied to complex perianal fistulas. We systematically reviewed the current evidence through meta-analysis. METHODS: We performed an electronic literature search on PubMed, Embase, and the Cochrane Library and identified studies (published between January 1946 and August 2017) that used stem cells to treat patients with complex perianal fistula. Each paper was evaluated for treatment success rate, target patients, types of stem cells used, number of cells used, and criteria for complete healing. Potential publication bias was assessed via visual inspection of a funnel plot and Orwin's fail-safe N. Out of 171 papers, 16 were included in the meta-analysis. RESULTS: The overall healing rate of stem cell injection therapy for patients with complex perianal fistulas was 62.8% (95% CI 53.5-71.2, I2 = 54.05%), whereas those for patients with Crohn's perianal fistulas alone and complex anal fistulas not associated with Crohn's disease were 64.1% and 61.5% (p = 0.840), respectively. Healing rates for autologous and allogenic stem cell treatment were 69.4% and 50.7% (p = 0.020), respectively. Four comparative studies out of 16 studies were analyzed separately. Stem cell therapy increased the healing rate compared to the control groups (OR 0.379, 95% CI 0.152-0.947). CONCLUSIONS: Stem cell therapy is a good treatment option for complex perianal fistulas, which cannot be healed by conventional operative procedures. However, further research for additional supportive evidence, such as a large-scale randomized controlled trial, is required.
Authors: Rasmy Loungnarath; David W Dietz; Matthew G Mutch; Elisa H Birnbaum; Ira J Kodner; James W Fleshman Journal: Dis Colon Rectum Date: 2004-02-25 Impact factor: 4.585
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: Manuel A González; Elena Gonzalez-Rey; Laura Rico; Dirk Büscher; Mario Delgado Journal: Gastroenterology Date: 2008-11-27 Impact factor: 22.682
Authors: Paul J van Koperen; Andre D'Hoore; Albert M Wolthuis; Willem A Bemelman; J Frederik M Slors Journal: Dis Colon Rectum Date: 2007-12 Impact factor: 4.585
Authors: H Aurich; M Sgodda; P Kaltwasser; M Vetter; A Weise; T Liehr; M Brulport; J G Hengstler; M M Dollinger; W E Fleig; B Christ Journal: Gut Date: 2008-11-20 Impact factor: 23.059
Authors: Anne-Marie Rodriguez; Didier Pisani; Claude A Dechesne; Claude Turc-Carel; Jean-Yves Kurzenne; Brigitte Wdziekonski; Albert Villageois; Claude Bagnis; Jean-Philippe Breittmayer; Hervé Groux; Gérard Ailhaud; Christian Dani Journal: J Exp Med Date: 2005-05-02 Impact factor: 14.307
Authors: G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi Journal: Tech Coloproctol Date: 2020-03-14 Impact factor: 3.781
Authors: Noemi Eiro; Maria Fraile; Alberto González-Jubete; Luis O González; Francisco J Vizoso Journal: Int J Mol Sci Date: 2022-08-10 Impact factor: 6.208